BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28432433)

  • 1. Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome.
    Wari MN; Vallonthaiel AG; Ahmed A; Saxena D; Iyer VK; Mathur SR; Agarwala S; Bakhshi S; Srinivas V; Chattopadhyaya P; Sharma A; Gupta SD; Dinda A
    Pediatr Surg Int; 2017 Jun; 33(6):695-703. PubMed ID: 28432433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
    Salama A; Kamel A
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
    Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
    J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
    Aronson DC; Hadley GP
    Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glypican 3 overexpression in primary and metastatic Wilms tumors.
    Tretiakova M; Zynger DL; Luan C; Andeen NK; Finn LS; Kocherginsky M; Teh BT; Yang XJ
    Virchows Arch; 2015 Jan; 466(1):67-76. PubMed ID: 25366870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis.
    Guo F; Zhang LJ; Liu W; Wang G; Liu HY; Wang YL; Ma R; Wu RD
    J Pediatr Urol; 2014 Apr; 10(2):317-23. PubMed ID: 24119914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
    Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
    Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms' tumor.
    Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
    J Pediatr Surg; 2017 Aug; 52(8):1348-1354. PubMed ID: 28040201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of pediatric nephroblastoma in southern Thailand.
    Sangkhathat S; Chotsampancharaen T; Kayasut K; Patrapinyokul S; Chiengkriwate P; Kitichet R; Maipang M
    Asian Pac J Cancer Prev; 2008; 9(4):643-7. PubMed ID: 19256753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.
    Fernandez CV; Perlman EJ; Mullen EA; Chi YY; Hamilton TE; Gow KW; Ferrer FA; Barnhart DC; Ehrlich PF; Khanna G; Kalapurakal JA; Bocking T; Huff V; Tian J; Geller JI; Grundy PE; Anderson JR; Dome JS; Shamberger RC
    Ann Surg; 2017 Apr; 265(4):835-840. PubMed ID: 27811504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
    An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
    J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    Suita S; Kinoshita Y; Tajiri T; Hara T; Tsuneyoshi M; Mizote H; Inada H; Takamatsu H; Kawano Y; Inomata Y; Nagasaki A; Ono Y; Handa N; Okamura J; Ishii E; Kawakami K;
    J Pediatr Surg; 2006 Sep; 41(9):1501-5. PubMed ID: 16952581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
    Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
    Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican-3 expression in Wilms tumor and hepatoblastoma.
    Toretsky JA; Zitomersky NL; Eskenazi AE; Voigt RW; Strauch ED; Sun CC; Huber R; Meltzer SJ; Schlessinger D
    J Pediatr Hematol Oncol; 2001 Nov; 23(8):496-9. PubMed ID: 11878776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
    Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
    J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.
    Hazen-Martin DJ; Re GG; Garvin AJ; Sens DA
    Am J Pathol; 1994 May; 144(5):1023-34. PubMed ID: 8178926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.